Optimization of immunologic testing

Designing serological assays with high diagnostic potential

In the hopes of creating a more accurate and highly informative diagnostic test, CITF-funded investigator Dr. Andrei Drabovich (University of Alberta) and colleagues have designed and evaluated the performance of novel serological assays to measure the presence of SARS-CoV-2 antibodies in blood and saliva. Their study is published in Analytical Chemistry.

2022-09-26T15:55:16-04:00September 26, 2022|Optimization of immunologic testing|

Dried blood spots can be a reliable test to detect SARS-CoV-2 antibodies

In a study now published in Microbiology Spectrum, a team of Vancouver investigators, led by Dr. Agatha Jassem of the British Columbia Center for Disease Control (BCCDC) and partially funded by the CITF, demonstrated that dried blood spot (DBS) testing should be considered reliable in detecting SARS-CoV-2 seropositivity acquired from both natural infection and vaccination.

2022-04-19T10:29:52-04:00March 18, 2022|Optimization of immunologic testing|
Go to Top